Emphymab Biotech, a seed stage company created and supported by the Indiana University Research and Technology Corp. Spin-Up program, was recently named a winner in the 2013 Innovation Showcase.
Emphymab is developing disease-modifying therapeutics for chronic obstructive pulmonary disease based on research by Irina Petrache, M.D., the Dr. Calvin H. English Professor of Medicine and a pulmonary specialist at the IU School of Medicine, and Matthias Clauss, Ph.D., associate professor of cellular and integrative physiology.
The company won “Best Seed Pitch” after more than 60 companies gave 60-second pitches to compete in the showcase, hosted by the Venture Club of Indiana. As the winner, Emphymab received a prize worth $60,000, with $5,000 in cash and the remainder in legal, accounting, communications and other services from local firms.
Learn more about Emphymab Biotech.
Leave a Reply